Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia)

European Journal of Clinical Investigation
S M HaffnerW R Hazzard

Abstract

These studies were conducted to investigate whether subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia) can catabolize chylomicrons normally and if chylomicron catabolism is related to the triglyceride pool size. Iodinated postprandial plasma chylomicrons were injected into subjects with dysbetalipoproteinaemia (n = 7), subjects with endogenous hypertriglyceridaemia (n = 4), and normal subjects (n = 5). The subjects with dysbetalipoproteinaemia had VLDL-cholesterol/total triglyceride ratios greater than 0.35 and were deficient in isoapoE-3 and isoapoE-4. The decay of radioactivity in chylomicron apoB was measured and residence times (RT) were calculated by measuring the area under the radioactivity decay curve. The mean RT for chylomicron apoB in subjects with dysbetalipoproteinaemia was 17.4 +/- 3.5 h, which was significantly longer than in both subjects with endogenous hypertriglyceridaemia (4.8 +/- 2.1 h) and also in normal subjects (5.9 +/- 1.6 h). There was no significant correlation between chylomicron apoB RT and triglyceride levels in subjects with dysbetalipoproteinaemia or in other subjects. Thus, chylomicron apoB catabolism is retarded in subjects with dysbetalipoproteinaemia. The slow removal of c...Continue Reading

References

Nov 1, 1979·Metabolism: Clinical and Experimental·A P GoldbergW R Hazzard
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J DavignonC F Sing
Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A F StalenhoefR J Havel
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·C EhnholmJ L Witztum
Jan 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J P KaneR J Havel
Jul 5, 1958·Nature·A S McFARLANE

❮ Previous
Next ❯

Citations

Nov 3, 1998·Journal of Internal Medicine·M C CabezasD W Erkelens
May 3, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katsuyuki NakajimaAkira Tanaka
Jan 9, 2018·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katsuyuki Nakajima, Akira Tanaka
Mar 22, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katsuyuki NakajimaMasami Murakami

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.